Delivery Order SPE2DB22D1106-SPE2DB24FFAX4

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,217.72 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product "MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML" with a completion date of May 10, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,742.92 firm fixed price delivery order covers the procurement of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a period of performance through February 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,367.48, is a delivery order for the medical product "MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML". The contract has an ultimate completion date of February 19, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,354.15 firm-fixed-price delivery order is for the medical product "MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML". The contract has a completion date of December 5, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $337,273.49 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines, with a period of performance through May 19, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a $1,342.88 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS) medical supplies, with a performance period ending on May 22, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This federal contract award is a delivery order valued at $37,825.20 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with an ultimate completion date of May 28, 2025. The contract is a firm fixed-price arrangement and is not set aside for any particular business type. AmerisourceBergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $39,575.25 firm-fixed-price contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of August 6, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans'...
This is a $49,898.94 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA). The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML pharmaceutical products, with a completion date of April 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is not operating under a set-aside for this award. The contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,561.85 firm fixed-price delivery order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of September 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFAX4
    Delivery Order

This $12,177 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the medical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML. The contract has an ultimate completion date of July 10, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/17/25, 9:46 AM